2,3-bis(4-hydroxyphenyl)-propionitrile and Autoimmune Thyroiditis

2,3-bis(4-hydroxyphenyl)-propionitrile has been researched along with Autoimmune Thyroiditis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Fan, C; Guo, D; Jin, Q; Li, J; Li, L; Liu, M; Qin, J; Shan, Z; Teng, W	1

Other Studies

1 other study(ies) available for 2,3-bis(4-hydroxyphenyl)-propionitrile and Autoimmune Thyroiditis

Article	Year
Estrogen receptor β activation stimulates the development of experimental autoimmune thyroiditis through up-regulation of Th17-type responses. Clinical immunology (Orlando, Fla.), 2018, Volume: 190 Topics: Animals; Antigen-Presenting Cells; Estrogen Receptor beta; Female; Gene Expression; Interleukin-17; Interleukins; Mice, Inbred CBA; Nitriles; Nuclear Receptor Subfamily 1, Group F, Member 3; Ovariectomy; Propionates; Th17 Cells; Thyroiditis, Autoimmune; Up-Regulation	2018

Article

Year

Estrogen receptor β activation stimulates the development of experimental autoimmune thyroiditis through up-regulation of Th17-type responses.

Clinical immunology (Orlando, Fla.), 2018, Volume: 190

Topics: Animals; Antigen-Presenting Cells; Estrogen Receptor beta; Female; Gene Expression; Interleukin-17; Interleukins; Mice, Inbred CBA; Nitriles; Nuclear Receptor Subfamily 1, Group F, Member 3; Ovariectomy; Propionates; Th17 Cells; Thyroiditis, Autoimmune; Up-Regulation

2018